13th European AIDS Conference

October 12-15, 2011 - Belgrade, Serbia

EACS 2011: Multiple Regimens Are Used for First-Line HIV Treatment, but Outcomes Are Similar

Initial antiretroviral therapy (ART) regimens vary widely according to patient characteristics and provider preferences, but most commonly used multi-class combination regimens appear to work about equally well, according to research presented at the 13th European AIDS Conference (EACS 2011) this month in Belgrade.alt

Read more:

EACS 2011: Does Maraviroc Intensification Promote Better CD4 Cell Recovery?

Adding maraviroc (Selzentry or Celsentri) to a suppressive antiretroviral regimen may help promote CD4 T-cell recovery in a subset of patients who experience poor immunological response to treatment, according to 2 studies presented at the 13th European AIDS Conference (EACS 2011) this month in Belgrade.alt

Read more:

Guidelines Galore: U.S. and EACS Update HIV Recommendations, AASLD Revision Adds New HCV Drugs

On October 14, 2011, the U.S. Department of Health and Human Services (DHHS) issued updated guidelines for the use of antiretroviral therapy in adults and adolescents.

The European AIDS Clinical Society (EACS) released revised guidelines the same day at the 13th European AIDS Conference in Belgrade.alt

Read more:

EACS 2011: Predictors of HCV Viral Load in HIV/HCV Coinfected Patients

Hepatitis C virus (HCV) RNA levels rise over time in HIV/HCV coinfected people, reducing the chances of sustained response to interferon-based treatment. But antiretroviral therapy may help control HCV viral load and contribute to higher likelihood of treatment success, according to a report presented at the 13th European AIDS Conference (EACS 2011) this month in Belgrade.alt

Read more:

New Guidance Addresses Expanded Antiretroviral Treatment, Perinatal ART, and PrEP

On October 14, 2011, the U.S. Department of Health and Human Services (DHHS) issued updated guidelines for the use of antiretroviral therapy in adults and adolescents.

The European AIDS Clinical Society (EACS) released revised guidelines the same day at the 13th European AIDS Conference in Belgrade.

The American Association for the Study of the Liver (AASLD) this month released new guidelines for the treatment of genotype 1 chronic hepatitis C, including information about boceprevir (Victrelis) and telaprevir (Incivek).alt

Read more: